Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Gleevec (Imatinib mesylate)
DRUG
2 trials
Sponsors
M.D. Anderson Cancer Center
Conditions
Leukemia, Myeloid, Chronic
Solid Tumor
Thyroid Cancer
Phase 1
Zarnestra and Gleevec in Chronic Phase Chronic Myelogenous Leukemia
Completed
NCT00040105
M.D. Anderson Cancer Center
Leukemia, Myeloid, Chronic
Start: 2002-10-31
End: 2009-03-31
Updated: 2012-08-01
Imatinib in Combination With Dacarbazine and Capecitabine in Medullary Thyroid Carcinoma
Terminated
NCT00354523
M.D. Anderson Cancer Center
Solid Tumor, Thyroid Cancer
Start: 2004-12-31
End: 2013-08-31
Updated: 2014-12-17
Related Papers
A phase I study of imatinib, dacarbazine, and capecitabine in advanced endocrine cancers.
2014-08-02
15 citations